Guest guest Posted March 29, 2011 Report Share Posted March 29, 2011 News 4 new results for hepatitis c Cyplasin Biomedical Ltd Announces Name Change And Creation of a Subsidiary C ...CNW Group (press release)The Company is pleased to announce that in order to better reflect multiple new product development opportunities and to continue its current product development programs for Hepatitis C; will effective immediately, change its name to Compass ...See all stories on this topic » Tibotec Advances Global Clinical Research Program for TMC435 in HCV; Will ...PharmaLive.com (press release)CORK, Ireland, March 29, 2011 /PRNewswire/ -- Tibotec Pharmaceuticals announced today that four abstracts reporting research findings with TMC435, the company's investigational hepatitis C protease inhibitor, have been accepted for presentation at the ...See all stories on this topic » Vertex Notches Another VictoryMinyanville.comWhat Vertex has going for it is a promising one-two punch of late-stage developmental drugs to treat hepatitis C and cystic fibrosis, two troublesome diseases that present large market opportunities. Last month, Vertex said its cystic fibrosis VX-770 ...See all stories on this topic » Concern over fall in organ donationsIrish TimesHe said patients with alcoholic liver disease probably account for about 30 per cent of patients who are transplanted and patients with hepatitis C probably account for about 35 to 40 per cent. Some two-third of the hepatitis C patients requiring liver ...See all stories on this topic » Irish Times Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.